Pfizer · 21 hours ago
Associate Statistical Programmer
Pfizer is a leading pharmaceutical company, and they are seeking an Associate Statistical Programmer to support study and asset teams in delivering statistical programming deliverables. The role involves ensuring high-quality programming standards and documentation while providing QC support for programming deliverables.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Accountable for their assigned work in the programming space supporting the programming leads for a particular project, study or asset deliverable
Will primarily provide supportive QC work for other programmers deliverables
Ensures appropriate documentation and QC documentation for their deliverables
Works with programming leads to ensure clear specifications for their programmed deliverables are in place
Will be learning in the space of programming and data standards
Qualification
Required
Bachelor or Master (preferred) Degree in Statistics, Biological Sciences, IT, or related field
At least 1 year relevant experience in SAS programming and knowledge of clinical trials
Statistical Programming and SAS/R hand-on experience
Working knowledge of clinical data
Strong written and oral communication skills, and time management skills
Proven ability to manage timelines
Preferred
CDISC experience desirable
Experience with PK/PD, Biomarker, Pharmacogenomics or Real World Data desirable
R programming experience desirable
Benefits
Participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary
401(k) plan with Pfizer Matching Contributions
An additional Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.
Funding
Current Stage
Public CompanyTotal Funding
$38BKey Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B
Recent News
2026-01-22
Maryland Daily Record
2026-01-22
Company data provided by crunchbase